IDRA‑21: New AMPA PAM Shakes Up Memory Trial – Thoughts

Posted by greg208 in Research & News - 1 points, 0 comments.

org/peptides/idra-21) that shows a single oral dose of 20 mg in mice improves memory consolidation and learning speed for 48‑72 hours. They used a standard Morris water maze and reported a 30 % improvement in escape latency after the first dose, with effects persisting even after the drug is gone. For me the idea of an AMPA PAM that stays in the brain for a vurdering of a couple of days is exciting – it feels like a middle ground between nootropics that wear off quickly and more permanent neural changesextensions.

The authors note the theoretical risk of excitotoxicity and keep the dose low, but I worry about the headache reports they mention and the fact that the safety window in rodents might not translate cleanly to humans. I’ve had a few days where a low dose of an AMPA modulator seemed to help focus, but the headaches turned my coffee to a brew of headaches. Are you all seeing any real cognitive lift with AMPA PAMs, or is it just a placebo buzz?

Community discussion - research and educational context only. Not medical advice.